Wednesday, February 07, 2018 9:57:05 AM
Data readout does selection ARS 1H17
Contract with U.S. Government for ARS 2H17
Initiation of pivotal study ARS NHP 2H17
Data readout phase 1 open label HCT 2H17
Preclinical data Fukushima 1H17
Preclinical data NYBC 1H17
U.S/Europe phase 3 study initiation 1Q17
Japan pivitol study initiation 2H17
Closing on JV deal with Sosei 1Q17
Data from IC multinational phase 2 early 2018
Interim results from Europe phase 3 CLI 2H18-1H19
And at the bottom with milestones for 12 months a couple more.
Initially trial hip fracture
Licensing deal JV with China.
Misses on vast majority of them. Some by 7 months now. So why the delay on preclinical data from Fukushima and NYBC. Having trouble enrolling mice?
But I'm ok with management.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM